The modulation of PD-L1 induced by the oncogenic HBXIP for breast cancer growth-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The modulation of PD-L1 induced by the oncogenic HBXIP for breast cancer growth

Published:2021-04-06 Issue:2 Volume:43 Page:429-445
ISSN:1671-4083
Container-title:Acta Pharmacologica Sinica
language:en
Short-container-title:Acta Pharmacol Sin

Author:

Xu Fei-fei,Sun Hui-min,Fang Run-ping,Zhang Lu,Shi Hui,Wang Xue,Fu Xue-li,Li Xian-meng,Shi Xu-he,Wu Yue,Ye Kai,Zhang Wei-ying,Ye Li-hong

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.nature.com/articles/s41401-021-00631-6.pdf

Reference76 articles.

1. Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer. 2012;12:252–64.

2. Cai G, Karni A, Oliveira EM, Weiner HL, Hafler DA, Freeman GJ. PD-1 ligands, negative regulators for activation of naive, memory, and recently activated human CD4+ T cells. Cell Immunol. 2004;230:89–98.

3. Lim SO, Li CW, Xia W, Cha JH, Chan LC, Wu Y, et al. Deubiquitination and stabilization of PD-L1 by CSN5. Cancer Cell. 2016;30:925–39.

4. Cao D, Qi Z, Pang Y, Li H, Xie H, Wu J, et al. Retinoic acid-related orphan receptor C regulates proliferation, glycolysis, and chemoresistance via the PD-L1/ITGB6/STAT3 signaling axis in bladder cancer. Cancer Res. 2019;79:2604–18.

5. Ritprajak P, Azuma M. Intrinsic and extrinsic control of expression of the immunoregulatory molecule PD-L1 in epithelial cells and squamous cell carcinoma. Oral Oncol. 2015;51:221–8.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PTMs of PD-1/PD-L1 and PROTACs application for improving cancer immunotherapy;Frontiers in Immunology;2024-04-04

2. Research progress on oncoprotein hepatitis B X‑interacting protein (Review);Molecular Medicine Reports;2024-04-03

3. Targeting the PD-L1 cytoplasmic domain and its regulatory pathways to enhance cancer immunotherapy;Journal of Molecular Cell Biology;2023-11-22

4. Challenges Coexist with Opportunities: Spatial Heterogeneity Expression of PD‐L1 in Cancer Therapy;Advanced Science;2023-11-07

5. Integrins and Actions of Androgen in Breast Cancer;Cells;2023-08-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3